Inhibitors of mammalian central nervous system selective amino acid transporters

被引:11
作者
Armer, RE [1 ]
机构
[1] Organon Res Labs Ltd, Dept Med Chem, Newhouse ML1 5SH, Lanark, Scotland
关键词
D O I
10.2174/0929867003375380
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Central nervous system (CNS) selective amino acid transporters provide an important function in maintaining tonic extracellular levels of amino acids that act as neurotransmitters, synaptic modulators or neurotransmitter precursors. Small molecule inhibitors of these transporters have been postulated and in some cases demonstrated to be useful in the treatment of a range of CNS driven disorders such as epilepsy, anxiety, psychosis, depression, pain and neurodegenerative disease. Although much of the research to date in this field has focussed on inhibition of the gamma-amino butyric acid (GABA) transporters more recent reports have also generated interest in modulation of glycine, glutamate and proline transporters. This article will review the current medicinal chemistry literature and structure activity relationships known for mammalian CNS selective amino acid transporters.
引用
收藏
页码:199 / 209
页数:11
相关论文
共 62 条
  • [1] Tiagabine - A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the management of epilepsy
    Adkins, JC
    Noble, S
    [J]. DRUGS, 1998, 55 (03) : 437 - 460
  • [2] ORALLY ACTIVE AND POTENT INHIBITORS OF GAMMA-AMINOBUTYRIC ACID UPTAKE
    ALI, FE
    BONDINELL, WE
    DANDRIDGE, PA
    FRAZEE, JS
    GARVEY, E
    GIRARD, GR
    KAISER, C
    KU, TW
    LAFFERTY, JJ
    MOONSAMMY, GI
    OH, HJ
    RUSH, JA
    SETLER, PE
    STRINGER, OD
    VENSLAVSKY, JW
    VOLPE, BW
    YUNGER, LM
    ZIRKLE, CL
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1985, 28 (05) : 653 - 660
  • [3] THE SYNTHESIS OF NOVEL GABA UPTAKE INHIBITORS .1. ELUCIDATION OF THE STRUCTURE-ACTIVITY STUDIES LEADING TO THE CHOICE OF (R)-1-[4,4-BIS(3-METHYL-2-THIENYL)-3-BUTENYL]-3-PIPERIDINECARBOXYLIC ACID (TIAGABINE) AS AN ANTICONVULSANT DRUG CANDIDATE
    ANDERSEN, KE
    BRAESTRUP, C
    GRONWALD, FC
    JORGENSEN, AS
    NIELSEN, EB
    SONNEWALD, U
    SORENSEN, PO
    SUZDAK, PD
    KNUTSEN, LJS
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (12) : 1716 - 1725
  • [4] Modulation of N-methyl-D-aspartate receptor function by glycine transport
    Bergeron, R
    Meyer, TM
    Coyle, JT
    Greene, RW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (26) : 15730 - 15734
  • [5] BIANCHI M, 1998, Patent No. 5750573
  • [6] 6-(4-phenyl-benzyloxy-methyl) guvacine. Synthesis, GABA uptake inhibitor and muscarinic properties.
    Bisel, P
    Gies, JP
    Schlewer, G
    Wermuth, CG
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (24) : 3025 - 3028
  • [7] BONDINELL WE, 1997, Patent No. 43902
  • [8] Bridges RJ, 1999, CURR PHARM DESIGN, V5, P363
  • [9] CONFORMATIONALLY DEFINED NEUROTRANSMITTER ANALOGS - SELECTIVE-INHIBITION OF GLUTAMATE UPTAKE BY ONE PYRROLIDINE-2,4-DICARBOXYLATE DIASTEREOMER
    BRIDGES, RJ
    STANLEY, MS
    ANDERSON, MW
    COTMAN, CW
    CHAMBERLIN, AR
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (02) : 717 - 725
  • [10] Castagna M, 1997, J EXP BIOL, V200, P269